Researchers at the @CUMedicalSchool are learning more about Rett syndrome and its effects on males with new funding in ACCORDS' most viewed blog of 2025: https://bit.ly/4pJJZOq
@cupediatrics.bsky.social @cumedicalschool.bsky.social
#ACCORDSInnovation #ACCORDSCommunity #HealthCareServicesResearch
A team of CU Researchers received funding to study the effectiveness of youth advisory boards in ACCORDS' 3rd most viewed blog of 2025: https://bit.ly/453KFpr
@cumedicalschool.bsky.social
#ACCORDSInnovation #ACCORDSCommunity #HealthCareServicesResearch
Inspired by her family, Channing Tate, PhD, has dedicated her career to serving the most vulnerable people in our 4th most read blog of 2025: https://bit.ly/4iZyGiD
@cumedicalschool.bsky.social
#ACCORDSInnovation #ACCORDSCommunity #HealthCareServicesResearch
Read about collaboration in team science with our 7th most read newsroom story of the year: news.cuanschutz.edu/accords/cu-anschutz-rese... @cupediatrics.bsky.social @cumedicalschool.bsky.social #ACCORDSCommunity #HealthCareServicesResearch
Two researchers hope to improve children’s safety, the effectiveness of care, and reduce unnecessary costs. Read more about their work in the 8th most viewed newsroom story of 2025: https://bit.ly/48XNs4T @cupediatrics.bsky.social #ACCORDSCommunity #HealthCareServicesResearch
In our 9th most viewed newsroom story of 2025, we hear from Christopher Stille, MD, who spent his career providing primary care for well children and children with special health care needs. bit.ly/49fsOyc
@cupediatrics.bsky.social #ACCORDSCommunity #HealthCareServicesResearch
The 10th most viewed newsroom story of 2025 for ACCORDS highlights the work of Susan Moore, PhD, MSPH. Read More: news.cuanschutz.edu/accords/mobi... @mhealthimpactlab.bsky.social
#ACCORDSInnovation #HealthCareServicesResearch
New Publication: "Liraglutide vs Semaglutide vs Dulaglutide in Veterans With Type 2 Diabetes" published in JAMA Network Open, co-authored by Catherine Derington, PharmD, MS, Assistant Professor of Cardiology and ACCORDS Investigator at CU Anschutz
Congratulations to Catherine Derington, PharmD, MS, CU Anschutz Ass't Prof of Cardiology and ACCORDS Investigator, who co-authored the publication, "Liraglutide vs Semaglutide vs Dulaglutide in Veterans With Type 2 Diabetes."
Read Now: lnkd.in/gDEaK9Vy #ACCORDSInnovation #HealthCareServicesResearch